Biotech & Synthetic Biology Report
: Analysis on the Market, Trends, and TechnologiesThe biotech and synthetic biology sector is experiencing significant growth and innovation, driven by advancements in gene synthesis, protein engineering, and precision fermentation. With over 20,000 companies operating in the field, the industry shows a promising future with substantial annual revenue and a high level of investor confidence. Key trends shaping the landscape include the development of novel biologic treatments, digital sales assistance, and the production of animal feed. The sector’s impact is further underscored by its role in employment growth and innovation. Despite its developing stage, the biotech & synthetic biology domain is attracting major investments, highlighting its potential for expansion and the need for strategic adjustments to sustain long-term success.
This report was last updated 5 days ago. Spot an error or missing detail? Help us fix it by getting in touch!
Topic Dominance Index of Biotech & Synthetic Biology
To identify the Dominance Index of Biotech & Synthetic Biology in the Trend and Technology ecosystem, we look at 3 different time series: the timeline of published articles, founded companies, and global search. These timelines are normalized and combined to show a comprehensive view of the Biotech & Synthetic Biology evolution relative to all known Trends and Technologies.
Key Activities and Applications
- Clinical stage biologic treatments for various diseases, with a focus on ischemic stroke and neurological disorders.
- Digital sales research assistance utilizing machine learning for industry insights.
- Production of animal feed for diverse animal types, emphasizing harmony with nature.
- Development of immunity-boosting protein powders and nutritional supplements.
- Preclinical stage companies dedicated to novel medicines for cancer and fibrotic diseases.
- Technologically advanced businesses concentrating on synthetic biology for natural product production.
- Specialty chemical manufacturing companies committed to clean and sustainable solutions.
- E-commerce platforms for biotech purchasing processes, streamlining online shopping for research materials.
Emergent Trends and Core Insights
- Gene synthesis and protein engineering are prominent trends, indicating a shift towards more precise and efficient biological manipulation.
- Precision fermentation emerges as a key trend, reflecting industry efforts to evolve landscape and product offerings.
- A steady growth in news coverage and the establishment of new companies suggests increasing public interest and sector vitality.
- The annual decline in new company growth indicates market saturation, necessitating strategic innovation for continued development.
- Significant investments from public entities and partners like Sofinnova Partners demonstrate a robust funding ecosystem for the sector.
Technologies and Methodologies
- Machine learning and AI are increasingly used for industry analysis, data identification, and trend prediction.
- CRISPR-Cas9 and other gene editing technologies are employed for genetic engineering and product enhancement.
- High-throughput screening and automation are leveraged for efficiency in drug discovery and development.
- E-commerce and digital platforms are utilized for efficient distribution and accessibility of biotech products and services.
Biotech & Synthetic Biology Funding
A total of 4.7K Biotech & Synthetic Biology companies have received funding.
Overall, Biotech & Synthetic Biology companies have raised $160.4B.
Companies within the Biotech & Synthetic Biology domain have secured capital from 12.1K funding rounds.
The chart shows the funding trendline of Biotech & Synthetic Biology companies over the last 5 years
Biotech & Synthetic Biology Companies
The Companies feature is a crucial part of TrendFeedr. It offers in-depth information about 20.2K companies working within Biotech & Synthetic Biology and other trends and technologies. Identify and analyze innovators and key players in relevant industries more easily with this feature.
20.2K Biotech & Synthetic Biology Companies
Discover Biotech & Synthetic Biology Companies, their Funding, Manpower, Revenues, Stages, and much more
Biotech & Synthetic Biology Investors
TrendFeedr’s investors tool offers a detailed view of investment activities that align with specific trends and technologies. This tool features comprehensive data on 3.2K Biotech & Synthetic Biology investors, funding rounds, and investment trends, providing an overview of market dynamics.
3.2K Biotech & Synthetic Biology Investors
Discover Biotech & Synthetic Biology Investors, Funding Rounds, Invested Amounts, and Funding Growth
Biotech & Synthetic Biology News
Stay informed and ahead of the curve with TrendFeedr’s News feature, which provides access to 79.4K Biotech & Synthetic Biology articles. The tool is tailored for professionals seeking to understand the historical trajectory and current momentum of changing market trends.
79.4K Biotech & Synthetic Biology News Articles
Discover Latest Biotech & Synthetic Biology Articles, News Magnitude, Publication Propagation, Yearly Growth, and Strongest Publications
Executive Summary
The biotech & synthetic biology sector is marked by dynamic growth and diversification, with significant contributions to healthcare, agriculture, and industrial processes. Investments and technological advancements have paved the way for innovative applications, from clinical treatments to digital platforms. Key trends like gene synthesis, protein engineering, and precision fermentation are reshaping the industry, offering new opportunities for growth. However, the sector must navigate challenges such as market saturation and the need for strategic adjustments to maintain its upward trajectory. As the field continues to evolve, continuous monitoring and adaptability will be critical for companies to thrive in this competitive landscape.
Interested in enhancing our coverage of trends and tech? We value insights from experts like you - reach out!
